Catalyst Wire Dossier Catalyst Wire Dossier

gemcitabine/cisplatin

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for gemcitabine/cisplatin, covering 2018-09-11 to 2024-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer [Phase 2]

See pricing